
About Kopran Research Laboratories Limited
Data last updated:
Kopran Research Laboratories Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Kopran Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 August 1986 and has been in existence for over 40 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1986PLC040601. Its GSTIN is 27AAACK3198E1ZJ (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹22.5 Cr. It was formerly known as Kopran Formulations Private Limited and Kopran Formulations Limited. It is led by directors including Chandra Mohan Singhi (Whole-Time Director) and Sunita Banerji.
Its last annual general meeting (AGM) was held on 10 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1076 Dr Emmoses Roadparijat House Worli, Mumbai, Maharashtra, India – 400018.
As per the financials filed for FY 2025, the company reported a revenue of ₹365.89 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹10.69 Cr (net margin 2.9%) and EBITDA of ₹32.7 Cr (EBITDA margin 8.9%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 14% over five years.
The company has about 609 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Kopran. As per MCA filings, the company has open charges of ₹194 Cr and satisfied charges of ₹39.5 Cr on record. Court records list 20 cases involving the company, including 7 filed by the company and 13 filed against it; 4 cases are pending. The company has 3 deals on record (1 rights issue, 1 secondary share transfer, 1 acquisition); the latest was in March 2022. Its 4 peer companies in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 3 smaller; the largest is Biochem Pharmaceutical Industries Limited Part IX with revenue of ₹366.61 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kopran.com.
Company details
Name history
Kopran Research Laboratories has undergone 2 name changes throughout its history. The company was previously known as Kopran Formulations Private Limited, and Kopran Formulations Limited. The current legal name is Kopran Research Laboratories Limited.
| Company Name | Status |
|---|---|
| Kopran Research Laboratories Limited | Current |
| Kopran Formulations Private Limited | Previous |
| Kopran Formulations Limited | Previous |
CIN history
Kopran Research Laboratories has one previous CIN (Corporate Identification Number): L24230MH1986PLC040601. The current CIN is U24230MH1986PLC040601, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH1986PLC040601 | Current |
| L24230MH1986PLC040601 | Previous |
Contact details
Kopran Research Laboratories Limited's registered office is in Mumbai, Maharashtra. Its website is kopran.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1076 Dr Emmoses Roadparijat House Worli, Mumbai, Maharashtra, India – 400018
- IndustryPharma, Drug Formulation & Development, API Manufacturers
To see the full contact details of Kopran Research Laboratories Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Kopran Research Laboratories operates one associated brand: Kopran. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical Company manufacturing a range of products | kopran.com |
Business activity
The main business activity of Kopran Research Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Kopran Research Laboratories Limited, buy the company report.
Financials of Kopran Research Laboratories Limited
FY 2024 filings availableKopran Research Laboratories Limited reported revenue of ₹365.89 Cr (up 13% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 13% growth in the latest year. EBITDA fell 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹32.7 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.69 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.9% | ||||
| Net Profit Margin | 2.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kopran Research Laboratories Limited, buy the company report.
Board of directors of Kopran Research Laboratories Limited
Kopran Research Laboratories has 5 current directors and 15 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunita Banerji Also directs: Shihan Enterprises Private Limited | Director | 01 Mar 2016 | 10 Years 8 Months | Current |
| Rakesh Arunkumar Doshi Also directs: Duram Pharmachem Private Limited | Director | 14 Nov 2017 | 9 Years 0 Months | Current |
| Chandra Mohan Singhi | Whole-Time Director | 24 Jun 2015 | 11 Years 4 Months | Current |
| Vandana Surendra Somani | Director | 18 Feb 2015 | 11 Years 8 Months | Current |
| Mamta Ashok Biyani | Director | 14 Nov 2017 | 9 Years 0 Months | Current |
Peer comparison
Kopran Research Laboratories Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biochem Pharmaceutical Industries Limited Part IX | ₹366.61 Cr (FY 2016) | 15.0% | Ahmedabad, Gujarat, India | |||
| Kopran Research Laboratories Limitedthis company | ₹365.89 Cr (FY 2025) | ₹10.69 Cr | 2.9% | 13.0% | 609 | Mumbai, Maharashtra, India |
| Geltec Private Limited | ₹362.73 Cr (FY 2025) | 7.0% | Mumbai, Maharashtra, India | |||
| Vital Laboratories Private Limited | ₹357.13 Cr (FY 2025) | 7.0% | Mumbai, Maharashtra, India | |||
| Mepro Pharmaceuticals Private Limited | ₹356.46 Cr (FY 2025) | 20.0% | Surendra Nagar, Gujarat, India |
To see the full peer comparison of Kopran Research Laboratories Limited, buy the company report.
Auditor
Kopran Research Laboratories Limited is audited by NGS & Co. LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NGS & Co. LLP | FY 2024 | 119850W |
Shareholding
The shareholding of Kopran Research Laboratories Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Kopran Research Laboratories Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jul 2020 | 100360412 | State Bank of India | ₹69.25 Cr | Open | |
| 09 May 2016 | 100028872 | Sbicap Trustee Company Limited | ₹124.75 Cr | Open | |
| 04 May 2023 | 100726717 | Others | ₹28 Cr | Satisfied | |
| 16 Mar 2021 | 100437722 | Yes Bank Limited | ₹11.5 Cr | Satisfied |
To see the full charge records of Kopran Research Laboratories Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Kopran Research Laboratories Limited has 3 deals on record (1 rights issue, 1 secondary share transfer, 1 acquisition); the latest was in March 2022.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Rights issue | ₹100 Cr | Investors: Kopran Limited |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: Kopran Lifesciences Limited Seller: Kopran Limited |
| Mar 2015 | Acquisition | ₹150 Cr | Buyer: Kopran Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Kopran Research Laboratories Limited has 20 court cases on record: 7 filed by Kopran Research Laboratories, 13 filed against it. 4 cases are pending and 16 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 17 | 11 | 4 |
| High courts | 3 | 2 | 0 |
Cases on record (5 of 20)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Court case (CRI APPEAL) | Filed against the company by Phoenix Biologicals Private Limited and Another Two in Ma 531/2025, Ba 593/2025 | Pending |
| District court, Raigad, Maharashtra | Civil suit | Filed by the company against Prizam Alliance Private Limited and 3 others | Pending |
| High Court | Court case (CARAP) | Filed against the company by Maxheal Pharmaceuticals India Limited | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Court case (CRI M A) | Filed against the company by Phoenix Biologicals Private Limited and Another Two in Appeal 177/2025, Ba 593/2025 | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Court case (CRI BAIL APPLN) | Filed against the company by Phoenix Biologicals Private Limited and Another Two in Appeal 177/2025, Ma 531/2025 | Disposed |
To see the full case history of Kopran Research Laboratories Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Kopran Research Laboratories Limited was last rated by Crisil on 07 Oct 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 07 Oct 2020 |
To see the full credit ratings and regulatory alerts of Kopran Research Laboratories Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kopran Research Laboratories Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Kopran Research Laboratories Limited has a workforce of 609 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 609 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Kopran Research Laboratories Limited, buy the company report.
GST
Kopran Research Laboratories has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACK3198E1ZJ | Maharashtra | Active | 01 Jul 2017 |
| 24AAACK3198E1ZP | Gujarat | Active | 01 Jun 2018 |
To see the full GST registrations and return filing status of Kopran Research Laboratories Limited, buy the company report.
Recent activity
Kopran Research Laboratories Limited has 15 board changes on record since 2011: 5 appointments and 10 cessations. The latest: Rakesh Arunkumar Doshi ceased to be Director on 31 Jul 2019.
14 earlier events are in the company report.
News
Frequently asked questions
Kopran Research Laboratories is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 August 1986 (40+ years old) and is registered under CIN U24230MH1986PLC040601.
Kopran Research Laboratories has 5 current directors:
- Chandra Mohan Singhi - Whole-Time Director
- Sunita Banerji - Director
- Rakesh Arunkumar Doshi - Director
- Vandana Surendra Somani - Director
- Mamta Ashok Biyani - Director
The latest financial statements of Kopran Research Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 10 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Kopran Research Laboratories is 27AAACK3198E1ZJ, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AAACK3198E1ZP (Gujarat).
The CIN (Corporate Identification Number) of Kopran Research Laboratories is U24230MH1986PLC040601. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kopran Research Laboratories has 20 court cases on record: 7 filed by the company and 13 filed against it. 4 are pending. Most are in the district courts.
Kopran Research Laboratories was incorporated on 12 August 1986, making it 40+ years old. It is registered with the Registrar of Companies, Mumbai.
Kopran Research Laboratories has 3 deals on record (1 rights issue, 1 secondary share transfer, 1 acquisition); the latest was in March 2022.
The peers of Kopran Research Laboratories by revenue are Biochem Pharmaceutical Industries Limited Part IX, Geltec Private Limited, Vital Laboratories Private Limited, Mepro Pharmaceuticals Private Limited, all in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rakesh Arunkumar Doshi ceased to be Director on 31 Jul 2019. Mamta Ashok Biyani ceased to be Additional Director on 17 Sep 2018. Mamta Ashok Biyani was appointed as Director on 14 Nov 2017. Kopran Research Laboratories has 15 board changes on record in total.
Kopran Research Laboratories can be reached through the website kopran.com. Its registered office is in Mumbai, Maharashtra, India.

